Breckenridge Pharmaceutical Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Breckenridge Pharmaceutical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3408
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Breckenridge Pharmaceutical Inc (Breckenridge), a subsidiary of Laboratorios Del Dr Esteve SA, is a healthcare solution provider that research, develops and markets various generic prescription products. The company offers products such as stradiol, oxcarbazepine tablets, methylprednisolone, polyethylene glycol powder, caffeine, codeine phosphate, meloxicam tablets, butalbital, acetaminophen, cyclobenzaprine, folic acid tablets and prednisone, among others. It produces its products in the dosage forms of tablets, capsules, liquids, suspensions, soft gel capsules, powders, and others. Breckenridge distributes products through a network of wholesalers, distributors, chains, managed care accounts and retail pharmacies, among others. The company has presence in Berlin, Boca Raton, Fairfield and New York. Breckenridge is headquartered in Boca Raton, Florida, the US.

Breckenridge Pharmaceutical Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Breckenridge Pharma Acquires Five ANDA’s from Nostrum Lab 10
Breckenridge Pharma Acquires ANDA from Impopharma 11
Breckenridge Pharma Completes Acquisition of Certain Generic Assets From Pernix Therapeutics For US$30 Million 12
Partnerships 14
Breckenridge Pharma Enters into Agreement with Sam Chun Dang Pharm 14
Breckenridge Pharma Enters into Marketing Agreement with Gland Pharma 15
Breckenridge Pharma Enters into Co-Marketing Agreement with MSN Labs for ANDAs 16
Breckenridge Pharma Enters into Co-Development Agreement with Pharmaceutics International 17
Breckenridge Pharma Enters Into Co-Development Agreement With Welding And SK Chemicals 18
Breckenridge Pharma Enters Into Co-Marketing Agreement With Aptalis Pharmatech For Inderal LA 19
Breckenridge Pharma Enters Into Co-Marketing Agreement With Marksans Pharma For Gabapentin Capsules 20
Breckenridge Pharma Enters Into Co-Marketing Agreement With Ajanta Pharma For Risperdal Tablet 21
Pamlab Enters Into Joint Venture With Breckenridge To Distribute Medical Food Products 22
Breckenridge Pharma Enters Into Co-Marketing Agreement With Zhejiang Huahai Pharma For Nevirapine 23
Breckenridge Pharmaceutical Inc – Key Competitors 24
Breckenridge Pharmaceutical Inc – Key Employees 25
Breckenridge Pharmaceutical Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Corporate Communications 27
Jul 10, 2018: Breckenridge Names Brian Guy As New President 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Key Facts 2
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Breckenridge Pharmaceutical Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Breckenridge Pharma Acquires Five ANDA's from Nostrum Lab 10
Breckenridge Pharma Acquires ANDA from Impopharma 11
Breckenridge Pharma Completes Acquisition of Certain Generic Assets From Pernix Therapeutics For US$30 Million 12
Breckenridge Pharma Enters into Agreement with Sam Chun Dang Pharm 14
Breckenridge Pharma Enters into Marketing Agreement with Gland Pharma 15
Breckenridge Pharma Enters into Co-Marketing Agreement with MSN Labs for ANDAs 16
Breckenridge Pharma Enters into Co-Development Agreement with Pharmaceutics International 17
Breckenridge Pharma Enters Into Co-Development Agreement With Welding And SK Chemicals 18
Breckenridge Pharma Enters Into Co-Marketing Agreement With Aptalis Pharmatech For Inderal LA 19
Breckenridge Pharma Enters Into Co-Marketing Agreement With Marksans Pharma For Gabapentin Capsules 20
Breckenridge Pharma Enters Into Co-Marketing Agreement With Ajanta Pharma For Risperdal Tablet 21
Pamlab Enters Into Joint Venture With Breckenridge To Distribute Medical Food Products 22
Breckenridge Pharma Enters Into Co-Marketing Agreement With Zhejiang Huahai Pharma For Nevirapine 23
Breckenridge Pharmaceutical Inc, Key Competitors 24
Breckenridge Pharmaceutical Inc, Key Employees 25
Breckenridge Pharmaceutical Inc, Other Locations 26

List of Figures
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Breckenridge Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Breckenridge Pharmaceutical Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • American Bio Medica Corp (ABMC):企業の製品パイプライン分析2018
    Summary American Bio Medica Corp (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, a point of collection testing product that detects 1-10 drugs of abuse in a urine specimen; Rapid One, a test cassette which is …
  • Livescribe Inc:企業の戦略的SWOT分析
    Livescribe Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Borders & Southern Petroleum plc (BOR):企業の財務・戦略的SWOT分析
    Summary Borders & Southern Petroleum Plc (Borders & Southern Petroleum) is an oil and gas company that offers exploration and development of hydrocarbons. The company holds interests in three production licenses in the Falkland Islands located south-east of the Islands. Its production licenses provi …
  • Discovery Communications Inc (DISCA):企業の財務・戦略的SWOT分析
    Discovery Communications Inc (DISCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Faron Pharmaceuticals Oy (FARN)-製薬・医療分野:企業M&A・提携分析
    Summary Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the tr …
  • Unikai Foods (P.J.S.C):企業の戦略・SWOT・財務分析
    Unikai Foods (P.J.S.C) - Strategy, SWOT and Corporate Finance Report Summary Unikai Foods (P.J.S.C) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mytrus Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mytrus Inc (Mytrus) is an e-clinical technology company that specializes in patient-centered electronic informed consent and data collection tools. The company’s technology includes Enroll, an electronic informed consent and patient enrollment system for clinical trials. Mytrus develops new …
  • Oriola-KD Oyj (OKDBV):企業の財務・戦略的SWOT分析
    Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • E. & J. Gallo Winery:企業の戦略・SWOT・財務情報
    E. & J. Gallo Winery - Strategy, SWOT and Corporate Finance Report Summary E. & J. Gallo Winery - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kancera AB (KAN):企業の財務・戦略的SWOT分析
    Summary Kancera AB (Kancera) is a developer of drug candidates for the treatment of cancer. The company’s pipeline products include fractalkine inhibitor AZD8797, used to stop tumor growth; small molecule HDAC6 inhibitors, for neutralizing blood cancer; small molecule PFKFB3 inhibitors, for stopping …
  • Snam S.p.A. (SRG):電力:M&Aディール及び事業提携情報
    Summary Snam S.p.A. (Snam) is an integrated midstream energy company. The company, through its subsidiaries, carries out the regasification, transportation, storage and supply of natural gas. Snam Rete Gas, its subsidiary, transports natural gas; GNL Italia conducts regasification; and Stogit stores …
  • TOA OIL Co Ltd (5008):企業の財務・戦略的SWOT分析
    Summary TOA OIL Co Ltd (TOA OIL), a subsidiary of Showa Shell Sekiyu KK is an oil and gas company that offers contract refining of crude oil. The company offers products such as diesel oil, coker naphtha scrubber, kerosene, polynaphtha units, LPG hydrofining unit, gasoline scrubber, and vacuum diese …
  • Grupo Grana y Montero SAA (GRAMONC1):企業の財務・戦略的SWOT分析
    Grupo Grana y Montero SAA (GRAMONC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Westinghouse Electric Co LLC:企業の戦略的SWOT分析
    Westinghouse Electric Co LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Dabur India Ltd (DABUR):企業の財務・戦略的SWOT分析
    Dabur India Ltd (DABUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • People’S Bank:企業の戦略・SWOT・財務分析
    People'S Bank - Strategy, SWOT and Corporate Finance Report Summary People'S Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Orlando Utilities Commission:企業の戦略的SWOT分析
    Orlando Utilities Commission - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Syngenta AG:企業の戦略・SWOT・財務分析
    Syngenta AG - Strategy, SWOT and Corporate Finance Report Summary Syngenta AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Geron Corp (GERN)-製薬・医療分野:企業M&A・提携分析
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …
  • Physiomics Plc (PYC):企業の財務・戦略的SWOT分析
    Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆